Background Asthma is a heterogeneous disease. Clinical blood parameters differ by
race/ethnicity and are used to distinguish asthma subtypes and inform therapies. Differences …

BACKGROUND: Information surrounding the long-term safety of combination inhaled
corticosteroid/long-acting β2-adrenergic agonist medications in African American asthmatic …

In the United States, substantial racial disparities exist in asthma prevalence, etiology,
morbidity and mortality, particularly between African Americans and white Americans …

Asthma is the most common chronic disease of children, with significant racial/ethnic
differences in prevalence, morbidity, mortality and therapeutic response. Albuterol, a …

: Asthma is a worldwide non-communicable disease affecting around 10% of children and
adults in France, with substantial socio-economic impacts. This is a complex chronic …

The present invention is directed to novel polymorphic crystal forms of a 5-(2-{[6-(2, 2-
difluoro-2-phenylethoxy) hexyl] amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2 (1H)-one …

Studying the biological markers in chronic obstructive pulmonary disease (COPD) and
asthma, two chronic respiratory diseases affecting millions of individuals around the world …

The general aim of the thesis was to assess the role of nutritional factors in asthma in the
French E3N study. The first objective was to compare principal component (PCA) with …

L'objectif principal de la thèse était de comprendre le rôle complexe des facteurs
nutritionnels dans l'asthme, avec une première partie portant sur l'alimentation et une …

US9108918B2 - Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
via a novel intermediate - Google Patents US9108918B2 - Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one …